Skip to main content
. 2016 Sep 7;7(41):66989–67003. doi: 10.18632/oncotarget.11888

Figure 8. The morphological changes of SGC-7901 and KATO-III cells after TGF-β1 treatment and the effects of TGF-β1 on E-cadherin expression (×200).

Figure 8

(A–E) The E-cadherin expression in SGC-7901 cells in the blank group, negative control group, miR-21 inhibitors group, PTEN-siRNA group and miR-21 inhibitors + PTEN-siRNA group; (F–J) the E-cadherin expression in KATO-III cell in the blank group, negative control group, miR-21 inhibitors group, PTEN-siRNA group and miR-21 inhibitors + PTEN-siRNA group).